389 related articles for article (PubMed ID: 26712781)
1. HTLV-1, Immune Response and Autoimmunity.
Quaresma JA; Yoshikawa GT; Koyama RV; Dias GA; Fujihara S; Fuzii HT
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712781
[TBL] [Abstract][Full Text] [Related]
2. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
Kagdi H; Demontis MA; Ramos JC; Taylor GP
PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
[TBL] [Abstract][Full Text] [Related]
3. Rate of positive autoimmune markers in Human T lymphotropic virus type 1 carriers: a case-control study from Iran.
Ahmadi Ghezeldasht S; Hedayati-Moghaddam MR; Habibi M; Mollahosseini F; Rafatpanah H; Miri R; Hatef Fard M; Sahebari M
Int J Rheum Dis; 2018 Jan; 21(1):108-113. PubMed ID: 28261958
[TBL] [Abstract][Full Text] [Related]
4. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.
Malta TM; Silva IT; Pinheiro DG; Santos AR; Pinto MT; Panepucci RA; Takayanagui OM; Tanaka Y; Covas DT; Kashima S
AIDS Res Hum Retroviruses; 2013 May; 29(5):826-36. PubMed ID: 23301858
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory manifestations of HTLV-1 and their therapeutic options.
Martin F; Taylor GP; Jacobson S
Expert Rev Clin Immunol; 2014 Nov; 10(11):1531-46. PubMed ID: 25340428
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune syndrome in the tropical spastic paraparesis/myelopathy associated with human T-lymphotropic virus infections].
Domínguez MC; Torres M; Tamayo O; Criollo W; Quintana M; Sánchez A; García F
Biomedica; 2008 Dec; 28(4):510-22. PubMed ID: 19462556
[TBL] [Abstract][Full Text] [Related]
8. Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus.
Lipka K; Tebbe B; Finckh U; Rolfs A
Clin Exp Dermatol; 1996 Jan; 21(1):38-42. PubMed ID: 8689767
[TBL] [Abstract][Full Text] [Related]
9. Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity.
Kannagi M; Hasegawa A; Kinpara S; Shimizu Y; Takamori A; Utsunomiya A
Cancer Sci; 2011 Apr; 102(4):670-6. PubMed ID: 21219540
[TBL] [Abstract][Full Text] [Related]
10. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
11. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
Nakamura T
Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to HTLV-I(ACH) during acute infection of pig-tailed macaques.
McGinn TM; Wei Q; Stallworth J; Fultz PN
AIDS Res Hum Retroviruses; 2004 Apr; 20(4):443-56. PubMed ID: 15157363
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.
Terada K; Katamine S; Eguchi K; Moriuchi R; Kita M; Shimada H; Yamashita I; Iwata K; Tsuji Y; Nagataki S
Lancet; 1994 Oct; 344(8930):1116-9. PubMed ID: 7934493
[TBL] [Abstract][Full Text] [Related]
14. HTLV-1 and the host immune system: how the virus disrupts immune regulation, leading to HTLV-1 associated diseases.
Satou Y; Matsuoka M
J Clin Exp Hematop; 2010; 50(1):1-8. PubMed ID: 20505271
[TBL] [Abstract][Full Text] [Related]
15. HTLV-1-infected thymic epithelial cells convey the virus to CD4
Carvalho Barros LR; Linhares-Lacerda L; Moreira-Ramos K; Ribeiro-Alves M; Machado Motta MC; Bou-Habib DC; Savino W
Immunobiology; 2017 Dec; 222(12):1053-1063. PubMed ID: 28888743
[TBL] [Abstract][Full Text] [Related]
16. Lack of evidence for human T cell lymphotrophic virus type I or II infection in patients with systemic lupus erythematosus or rheumatoid arthritis.
Bailer RT; Lazo A; Harisdangkul V; Ehrlich GD; Gray LS; Whisler RL; Blakeslee JR
J Rheumatol; 1994 Dec; 21(12):2217-24. PubMed ID: 7535355
[TBL] [Abstract][Full Text] [Related]
17. [The immune response to human T-cell lymphotropic virus type 1].
Hanon E
Bull Mem Acad R Med Belg; 2002; 157(10-12):419-24; discussion 425. PubMed ID: 12854182
[TBL] [Abstract][Full Text] [Related]
18. Human T-cell leukemia virus type 1 and Foxp3 expression: viral strategy in vivo.
Miyazato P; Matsuoka M
Int Immunol; 2014 Aug; 26(8):419-25. PubMed ID: 24792037
[TBL] [Abstract][Full Text] [Related]
19. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity due to molecular mimicry as a cause of neurological disease.
Levin MC; Lee SM; Kalume F; Morcos Y; Dohan FC; Hasty KA; Callaway JC; Zunt J; Desiderio D; Stuart JM
Nat Med; 2002 May; 8(5):509-13. PubMed ID: 11984596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]